Trial Details
COMPLETEDBasic Information
| Clinical ID | c2852 |
|---|---|
| Identifier | NCT02877134 |
| Trial Title | Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: JNJ-64304500|DRUG: Placebo|DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Lone Tree |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-08-25 |
|---|---|
| Primary Completion Date | 2020-12-10 |
| Completion Date | 2022-01-24 |